Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00783172
Recruitment Status : Terminated (Problems with IRB)
First Posted : October 31, 2008
Last Update Posted : February 13, 2013
Milton S. Hershey Medical Center
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Jill P. Smith, Penn State University